232 related articles for article (PubMed ID: 25070948)
1. Excess SMAD signaling contributes to heart and muscle dysfunction in muscular dystrophy.
Goldstein JA; Bogdanovich S; Beiriger A; Wren LM; Rossi AE; Gao QQ; Gardner BB; Earley JU; Molkentin JD; McNally EM
Hum Mol Genet; 2014 Dec; 23(25):6722-31. PubMed ID: 25070948
[TBL] [Abstract][Full Text] [Related]
2. SMAD signaling drives heart and muscle dysfunction in a Drosophila model of muscular dystrophy.
Goldstein JA; Kelly SM; LoPresti PP; Heydemann A; Earley JU; Ferguson EL; Wolf MJ; McNally EM
Hum Mol Genet; 2011 Mar; 20(5):894-904. PubMed ID: 21138941
[TBL] [Abstract][Full Text] [Related]
3. Myofiber-specific inhibition of TGFβ signaling protects skeletal muscle from injury and dystrophic disease in mice.
Accornero F; Kanisicak O; Tjondrokoesoemo A; Attia AC; McNally EM; Molkentin JD
Hum Mol Genet; 2014 Dec; 23(25):6903-15. PubMed ID: 25106553
[TBL] [Abstract][Full Text] [Related]
4. TNAP limits TGF-β-dependent cardiac and skeletal muscle fibrosis by inactivating the SMAD2/3 transcription factors.
Arnò B; Galli F; Roostalu U; Aldeiri BM; Miyake T; Albertini A; Bragg L; Prehar S; McDermott JC; Cartwright EJ; Cossu G
J Cell Sci; 2019 Aug; 132(15):. PubMed ID: 31289197
[TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor-β (TGF-β) signaling in healthy human fetal skin: a descriptive study.
Walraven M; Beelen RH; Ulrich MM
J Dermatol Sci; 2015 May; 78(2):117-24. PubMed ID: 25795202
[TBL] [Abstract][Full Text] [Related]
6. Vascular smooth muscle cell Smad4 gene is important for mouse vascular development.
Mao X; Debenedittis P; Sun Y; Chen J; Yuan K; Jiao K; Chen Y
Arterioscler Thromb Vasc Biol; 2012 Sep; 32(9):2171-7. PubMed ID: 22772757
[TBL] [Abstract][Full Text] [Related]
7. Sarcoglycans in muscular dystrophy.
Hack AA; Groh ME; McNally EM
Microsc Res Tech; 2000 Feb 1-15; 48(3-4):167-80. PubMed ID: 10679964
[TBL] [Abstract][Full Text] [Related]
8. Autonomic, locomotor and cardiac abnormalities in a mouse model of muscular dystrophy: targeting the renin-angiotensin system.
Sabharwal R; Chapleau MW
Exp Physiol; 2014 Apr; 99(4):627-31. PubMed ID: 24334334
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of TGF-β signaling at the nuclear envelope: characterization of interactions between MAN1, Smad2 and Smad3, and PPM1A.
Bourgeois B; Gilquin B; Tellier-Lebègue C; Östlund C; Wu W; Pérez J; El Hage P; Lallemand F; Worman HJ; Zinn-Justin S
Sci Signal; 2013 Jun; 6(280):ra49. PubMed ID: 23779087
[TBL] [Abstract][Full Text] [Related]
10. Biochemical and Functional Comparisons of mdx and Sgcg(-/-) Muscular Dystrophy Mouse Models.
Roberts NW; Holley-Cuthrell J; Gonzalez-Vega M; Mull AJ; Heydemann A
Biomed Res Int; 2015; 2015():131436. PubMed ID: 26064876
[TBL] [Abstract][Full Text] [Related]
11. Latent TGF-beta-binding protein 4 modifies muscular dystrophy in mice.
Heydemann A; Ceco E; Lim JE; Hadhazy M; Ryder P; Moran JL; Beier DR; Palmer AA; McNally EM
J Clin Invest; 2009 Dec; 119(12):3703-12. PubMed ID: 19884661
[TBL] [Abstract][Full Text] [Related]
12. P38α MAPK underlies muscular dystrophy and myofiber death through a Bax-dependent mechanism.
Wissing ER; Boyer JG; Kwong JQ; Sargent MA; Karch J; McNally EM; Otsu K; Molkentin JD
Hum Mol Genet; 2014 Oct; 23(20):5452-63. PubMed ID: 24876160
[TBL] [Abstract][Full Text] [Related]
13. Dynamic analysis of the expression of the TGFbeta/SMAD2 pathway and CCN2/CTGF during early steps of tooth development.
Pacheco MS; Reis AH; Aguiar DP; Lyons KM; Abreu JG
Cells Tissues Organs; 2008; 187(3):199-210. PubMed ID: 18089935
[TBL] [Abstract][Full Text] [Related]
14. Cardiomyopathy is independent of skeletal muscle disease in muscular dystrophy.
Zhu X; Wheeler MT; Hadhazy M; Lam MY; McNally EM
FASEB J; 2002 Jul; 16(9):1096-8. PubMed ID: 12039854
[TBL] [Abstract][Full Text] [Related]
15. Anti-latent TGFβ binding protein 4 antibody improves muscle function and reduces muscle fibrosis in muscular dystrophy.
Demonbreun AR; Fallon KS; Oosterbaan CC; Vaught LA; Reiser NL; Bogdanovic E; Velez MP; Salamone IM; Page PGT; Hadhazy M; Quattrocelli M; Barefield DY; Wood LD; Gonzalez JP; Morris C; McNally EM
Sci Transl Med; 2021 Sep; 13(610):eabf0376. PubMed ID: 34516828
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of Latent TGFβ Binding Protein 4 in Muscle Ameliorates Muscular Dystrophy through Myostatin and TGFβ.
Lamar KM; Bogdanovich S; Gardner BB; Gao QQ; Miller T; Earley JU; Hadhazy M; Vo AH; Wren L; Molkentin JD; McNally EM
PLoS Genet; 2016 May; 12(5):e1006019. PubMed ID: 27148972
[TBL] [Abstract][Full Text] [Related]
17. Gene transfer establishes primacy of striated vs. smooth muscle sarcoglycan complex in limb-girdle muscular dystrophy.
Durbeej M; Sawatzki SM; Barresi R; Schmainda KM; Allamand V; Michele DE; Campbell KP
Proc Natl Acad Sci U S A; 2003 Jul; 100(15):8910-5. PubMed ID: 12851463
[TBL] [Abstract][Full Text] [Related]
18. Disruption of transforming growth factor beta-Smad signaling pathway in head and neck squamous cell carcinoma as evidenced by mutations of SMAD2 and SMAD4.
Qiu W; Schönleben F; Li X; Su GH
Cancer Lett; 2007 Jan; 245(1-2):163-70. PubMed ID: 16478646
[TBL] [Abstract][Full Text] [Related]
19. Increased Smad signaling and reduced MRF expression in skeletal muscle from obese subjects.
Watts R; McAinch AJ; Dixon JB; O'Brien PE; Cameron-Smith D
Obesity (Silver Spring); 2013 Mar; 21(3):525-8. PubMed ID: 23404842
[TBL] [Abstract][Full Text] [Related]
20. The expression dynamics of transforming growth factor-β/Smad signaling in the liver fibrosis experimentally caused by Clonorchis sinensis.
Yan C; Wang L; Li B; Zhang BB; Zhang B; Wang YH; Li XY; Chen JX; Tang RX; Zheng KY
Parasit Vectors; 2015 Feb; 8():70. PubMed ID: 25649869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
